Valuation Perrigo Company plc

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-02-13 pm EST			5-day change	1st Jan Change
14.54 ^USD	+1.11%		-0.68%	+4.45%

Jan. 12	Ansell Limited Announces Appointment of Ansell Limited as Independent Non-Executive Director , with Effect on March 1, 2026	CI
Dec. 21	Perrigo Company plc(NYSE:PRGO) added to S&P 600 Health Care	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	6,104	5,204	4,590	4,361	3,508	2,001	2,001	-
Change	-	-14.75%	-11.8%	-5%	-19.56%	-42.95%	0%	-
Enterprise Value (EV) ¹	9,028	6,859	8,096	7,683	6,567	4,954	4,658	4,556
Change	-	-24.02%	18.02%	-5.1%	-14.52%	-24.56%	-5.98%	-2.18%
P/E ratio	-37.6x	-74.8x	-32.8x	-358x	-20.6x	23.5x	11.5x	8.89x
PBR	1.05x	1.01x	0.95x	0.91x	-	0.45x	0.44x	0.43x
PEG	-	1.3x	-0x	3.9x	-0x	-0x	0x	0.3x
Capitalization / Revenue	1.21x	1.26x	1.03x	0.94x	0.8x	0.47x	0.48x	0.47x
EV / Revenue	1.78x	1.66x	1.82x	1.65x	1.5x	1.17x	1.12x	1.08x
EV / EBITDA	10.2x	11.9x	14x	11.6x	9.32x	6.84x	6.71x	6.27x
EV / EBIT	11.3x	14.3x	16.4x	13.4x	10.8x	7.89x	7.73x	7.41x
EV / FCF	19.4x	1,715x	38.4x	25.3x	26.8x	15.9x	11.9x	11.2x
FCF Yield	5.16%	0.06%	2.61%	3.95%	3.72%	6.29%	8.42%	8.91%
Dividend per Share ²	0.9	0.96	1.04	1.09	-	1.143	1.203	1.273
Rate of return	2.01%	2.47%	3.05%	3.39%	-	7.86%	8.28%	8.76%
EPS ²	-1.19	-0.52	-1.04	-0.09	-1.25	0.62	1.265	1.635
Distribution rate	-75.6%	-185%	-100%	-1,211%	-	184%	95.1%	77.9%
Net sales ¹	5,063	4,139	4,452	4,656	4,373	4,240	4,171	4,228
EBITDA ¹	885.6	578	576.9	663.9	704.9	724.5	693.6	726.4
EBIT ¹	795.8	479	492.3	574.3	608.5	627.6	602.2	615.2
Net income ¹	-162.6	-68.9	-140.6	-12.7	-171.8	86.45	175.7	226.8
Net Debt ¹	2,925	1,656	3,506	3,322	3,059	2,953	2,656	2,555
Reference price ²	44.72	38.90	34.09	32.18	25.71	14.54	14.54	14.54
Nbr of stocks (in thousands)	136,491	133,774	134,640	135,506	136,428	137,624	137,624	-
Announcement Date	3/1/21	3/1/22	2/27/23	2/27/24	2/27/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PERRIGO COMPANY PLC	23.45x	1.17x	6.84x	7.86%	2B
ELI LILLY AND COMPANY	31.13x	11.79x	23.7x	0.63%	929B
JOHNSON & JOHNSON	22.11x	6.52x	18.12x	2.12%	587B
ABBVIE INC.	64.64x	7.64x	18.92x	2.82%	409B
ROCHE HOLDING AG	18.87x	4.7x	11.65x	2.79%	374B
ASTRAZENECA PLC	32.49x	5.82x	17.36x	1.58%	320B
NOVARTIS AG	21.47x	6x	14.69x	2.7%	311B
MERCK & CO., INC.	15.68x	5.03x	10.97x	2.66%	301B
NOVO NORDISK A/S	14.81x	5.11x	10.76x	3.49%	219B
AMGEN INC.	28.69x	6.7x	11.46x	2.59%	199B
Average	27.33x	6.05x	14.45x	2.92%	365.07B
Weighted average by Cap.	29.08x	7.49x	17.21x	2.05%